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ABSTRACT 
With over half of the world population infected, Helicobacter infection is an important public 
health issue associated with gastrointestinal cancers and inflammatory bowel disease.  Animal 
studies indicate that complement and oxidative stress play a role in Helicobacter infections.  
Hemorrhage induces tissue damage which is attenuated by blockade of either complement 
activation or oxidative stress products.  Therefore, we hypothesized that chronic Helicobacter 
hepaticus infection would modulate hemorrhage-induced intestinal damage and inflammation.  
To test this hypothesis, we examined hemorrhage-induced jejunal damage and inflammation in 
uninfected and H. hepaticus infected mice.  H. hepaticus infection increased hemorrhage-
induced mid-jejunal mucosal damage despite attenuating complement activation.  In addition, 
infection alone increased chemokine secretion, changing the hemorrhage-induced neutrophil 
infiltration to a macrophage-mediated inflammatory response.  The hemorrhage-induced 
macrophage infiltration correlated with increased secretion of tumor necrosis factor-(TNF-) 
and nitric oxide (NO) in the infected mice.  Together these data indicate that Helicobacter 
infection modulates the mechanism of hemorrhage-induced intestinal damage and inflammation 
from a complement-mediated response to a macrophage response with elevated TNF- and NO.  
These data indicate that chronic, low level infections change the response to trauma and should 
be considered when designing and administering therapeutics. 
 
Key Words: Mouse, nitric oxide, inflammation, macrophage, CD55, jejunum 
      3 Non-standard abbreviations: CD55: Decay accelerating factor, DAF; TNF-: Tumor 
necrosis factor-alpha; NO: Nitric oxide; CXCL10: Chemokine (C-X-C motif) ligand 10; CCL3: 
C-C motif chemokine 3; MIP-1- Macrophage inflammatory protein  (CCL3); CCL4: C-C 
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motif chemokine 4; MIP-1: Macrophage inflammatory protein  (aka CCL3); CXCL1: 
Chemokine (C-X-C motif) ligand 1; CXCL10: Chemokine (C-X-C motif) ligand 10; IP-10: 10 
kDa interferon-gamma-induced protein (CXCL10); IL: Interleukin; KC-Keratinocyte derived 
protein (IL-8); LTB4 : Leukotriene B4; LPS: Lipopolysaccharide; IFN: Interferon gamma; PCR: 
Polymerase chain reaction; i.p.: Intraperitoneal injection; PMN: Polymorphonuclear leukocyte; 
SEM: Standard error of the mean; CVF: Cobra venom factor; TLR: Toll-like receptor 
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INTRODUCTION  
Chronic Helicobacter infections are found in over 50% of the adult population in the U.S. and up 
to 90% of the developing world population (1).  As the leading cause of peptic ulcers, chronic 
Helicobacter pylori infection is also implicated in gastrointestinal cancer and inflammatory 
bowel disease (1).  Recent studies associated other Helicobacter species with liver and colonic 
diseases including ulcerative colitis, inflammatory bowel disease and Crohn's disease (2).  
Similar to human diseases, Helicobacter hepaticus frequently remains undetected but can cause 
hepatitis in addition to the above mentioned diseases (3). 
 
Helicobacter-induced colonic inflammation involves significant inflammation which is 
characterized by chemokine and cytokine production.  Recent studies indicate that Helicobacter 
infections increase intestinal secretion of chemotactic factors CXCL10, CCL,3 CXCL2 and 
interleukin 8 (IL-8) or the murine homolog keratinocyte factor (KC) (3, 4).  These chemokines 
recruit both neutrophils and macrophages.  Other studies determined that Helicobacter infection 
increases cytokine expression by both leukocytes and gastric epithelium (5, 6).  Specifically, H. 
hepaticus increases tumor necrosis factor-TNF- and nitric oxide (NO) in the colon of 
infected, antibody-deficient, Rag-1-/- mice and in the liver of complement deficient mice (7, 8).  
However, after H. hepaticus infection, wildtype C57Bl/6 mice maintain cecal homeostasis with a 
decreased IL-12 response (5).  Despite the apparent resistance, colonic dendritic cells from H. 
hepaticus infected, C57Bl/6 mice differed from uninfected mice when further stimulated with E. 
coli LPS (9).  In response to herpes simplex virus type I, Helicobacter-infected mice also tended 
to have fewer IFN producing CD8+ T cells in the tracheobronchial lymph nodes (9).  Thus, 
despite no clinical signs of Helicobacter infection, the inflammatory response to subsequent 
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stimulation differs in infected animals. 
 
The Helicobacter-induced inflammatory response also includes complement activation.  
Complement activation is critical to gastric inflammation during Helicobacter felis infection, as 
complement depletion with either cobra venom factor (CVF) or treatment with anti-C5 
monoclonal antibody attenuates gastritis (10).  However, complement regulatory proteins on the 
mucosal surface prevent complement-mediated tissue damage and also appear to have a role in 
Helicobacter infections.  Expression of complement inhibitor CD55 (Decay Accelerating Factor; 
DAF) increases on the gastric epithelium of humans colonized with H. pylori (11).  In addition, 
the absence of DAF diminishes the Helicobacter-induced neutrophil infiltration and 
inflammatory response (11).  These data suggest that both complement activation and expression 
of complement inhibitors are affected by Helicobacter infection. 
 
As the primary cause of trauma-related morbidity and mortality, hemorrhage and the 
accompanying hemorrhagic-shock result in significant clinical complications due to hypoxic 
conditions and an excessive immune response (12, 13).  Because the splanchnic circulation 
receives 25-30% of the total blood volume, decreased systemic perfusion during hemorrhage 
results in lower intestinal blood flow, vasoconstriction and mucosal damage (14).  Hemorrhage 
and hemorrhagic-shock cause intestinal damage and inflammation in a neutrophil and 
complement-dependent manner (14-16).  Although oxidative stress and complement activation 
prevent bacterial infections, these molecules mediate tissue damage and inflammation when 
activated excessively.  Early changes in cytokine production indicate activation of the systemic 
inflammatory response during hemorrhagic shock and/or the presence of bacterial DNA (17).  
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Because cytokines, chemokines, oxidative stress and complement activation are critical in both 
infection and hemorrhage, we tested the hypothesis that chronic Helicobacter infection 
modulates mucosal damage and inflammation in a fixed-volume mouse model of hemorrhage. 
 
Our data demonstrate that Helicobacter infection significantly increases the chemotactic factors 
KC, CCL3 (MIP-1), CCL4 (MIP-1) and CXCL10 (IP-10) in the mid-jejunum.  Additionally, 
complement inhibitor CD55 expression increases in the jejunum, despite the absence of H. 
hepaticus DNA.  Consequently, complement activation does not play a role in the hemorrhage-
induced, jejunal inflammation and tissue damage in H. hepaticus infected mice.  Rather, in 
chronic Helicobacter infection, hemorrhage induces an influx of macrophages and TNF- and 
NO secretion in the jejunum.  Thus, although the specific bacterial mechanism is unknown, a 
chronic H. hepaticus infection in the liver and colon alters the mechanism of hemorrhage-
induced damage within the jejunum. 
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Materials and Methods: 
Mice: C57Bl/6 male mice (6-8 wks old) were bred and maintained at Kansas State University.  
All mice were housed in a 12-hour light-to-dark, temperature-controlled room and allowed food 
and water ad libitum.  Uninfected mice were maintained under specific pathogen free conditions 
(Helicobacter species, mouse hepatitis virus, minute virus of mice, mouse parvovirus, Sendai 
virus, murine norovirus, Mycoplasma pulmonis, Theiler’s murine encephalomyelitis virus, and 
endo- and ecto-parasites).  All research was approved by the Institutional Animal Care and Use 
Committee and conducted in compliance with the Animal Welfare Act and other Federal statutes 
and regulations concerning animals.   
 
Helicobacter Infection: Separately housed C57Bl/6 male mice were naturally colonized with H. 
hepaticus either by being reared by an infected female or by contact with infected feces during 
normal grooming.  The presence of H. hepaticus was verified by PCR analysis of the feces from 
each infected mouse (data not shown).  Fecal DNA was purified using the Qiagen DNA Stool 
mini kit according to the manufacturer’s protocol and PCR amplified for 35 cycles at 54oC using 
Helicobacter specific 16s rRNA primers: forward 5’ATG GGT AAG AAA ATA GCA AAA 
AGA TTG CAA3’ and reverse 5’CTA TTT CAT ATC CAT AAG CTC TTG AGA ATC 3’.  
PCR products were imaged using AlphaImager (Alpha Innotech) and semi-quantitative analysis 
performed using Image J (NIH).  Each mouse was infected for a minimum of 4-8 wks prior to 
hemorrhage.  Feces from uninfected mice were also analyzed by PCR with 100% negative 
results. Liver, cecum and colon DNA was purified by Trizol according to the manufacturer’s 
protocol and similar PCR analysis performed.  Preliminary data indicated a constant level of 
shed bacteria at 1- 2 mo post-infection (data not shown) with H. hepaticus DNA was also 
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detectable in the liver, cecum and colon of all mice.  In contrast, H. hepaticus DNA was found in 
the jejunum of only 10% of the infected mice (data not shown).   
 
Hemorrhage Protocol: Mice were anesthetized i.p. with ketamine (16 mg/kg) and xylazine (80 
mg/kg) and a drop of 0.5% proparacaine hydrochloride ophthalmic solution was applied to the 
appropriate eye.  The hemorrhage treated mice were subjected to 25% total blood volume 
removal via the retro-orbital sinus as described previously (15).  Blood volume removed was 
based on mouse weight (grams) and calculated using the following equation (~25% = grams x 
0.02) (16).  Sham-treated mice were subjected to similar procedures with no blood removal.  
Hemorrhage treatment was completed within five minutes.  Body temperature was maintained at 
37 C using a water-circulating heating pad and all procedures were performed with the animals 
breathing spontaneously.  At 1 h, 2 h or 3 h post-hemorrhage, mice were euthanized and 2 cm 
sections of mid-jejunum tissues collected and used for all further analysis.  The jejunum was 
used since previous studies indicated that hemorrhage induces significant damage within the 
mid-jejunum (15).  For C3 depletion studies, 7 units of cobra venom factor (CVF) (Quidel) was 
administered i.p. to mice at 24 h and 6 h prior to hemorrhage or Sham treatment.   
 
Intestinal Injury Score, Villus Height/Crypt Depth ratio and PMN infiltration: Formalin 
fixed mid-jejunal sections were transversely sectioned and stained with hematoxylin and eosin 
(H&E) for analysis of injury.  Injury was scored by an observer unaware of the treatment using a 
six-tiered scale adapted from Chiu et al. as described previously (15, 18).  Briefly, each villus 
was assigned a score as follows: 0- intact villus with no damage, 1- bulging of the epithelium, 2- 
Guggenheim’s space, 3- visible breakage of the epithelium, 4- exposure of intact lamina propria, 
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5- exuding of the lamina propria and 6- blood loss and denuding of the lamina propria.  The 
average intestinal injury of each animal was determined by grading 75-150 villi in approximately 
2 cm length of intestine.  Similarly, the number of neutrophils in at least 20 villi (from crypt to 
villus tip) per H&E stained slide was counted at 1000X magnification.  Villus height/crypt depth 
ratio of at least 15 individual villi per animal was measured using Metavue computer software on 
the H&E stained slide at 200X magnification All slides were examined by a blinded observer 
using a Nikon 80i microscope equipped with a DS Nikon color camera connected to the DS-L2 
controller unit. 
 
Cytokine, Chemokine, Leukotriene B4 and C5a production: Ex vivo intestinal supernatants 
were generated as described previously (15) and used to determine the secretions released in a 20 
min period.  Briefly, 2 cm mid-jejunal intestinal sections were minced, washed, re-suspended in 
37°C oxygenated Tyrode’s buffer and incubated for 20 min at 37oC.  Following incubation, the 
supernatants and tissues were collected and stored at -80oC until assayed.  After overnight 
digestion in 0.1M NaOH at 37oC, protein content in the intestinal tissue was determined using a 
BCA protein assay (Pierce).  Cytokine and chemokine concentrations in the intestinal 
supernatants were determined with a Milliplex MAP kit (Millipore) following the manufacturer's 
instructions and analyzed using MasterplexQT software (MiraiBio).  Leukotriene B4 (LTB4) 
concentrations in the intestinal supernatants were measured using a commercially available 
enzyme immunoassay kit (Cayman Chemicals).  All concentrations were normalized to the total 
intestinal protein content and reported as pg per mg of intestinal tissue.  Sera C5a concentrations 
were determined by capture ELISA (BD Biosciences).   
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Nitric oxide synthesis: Ex vivo mid-jejunal supernatants generated above were assayed for 
nitrite as a stable end product of NO and oxygen.  Equal volumes of supernatant and Griess 
reagent were incubated for 15 min prior to spectrophotometrically measuring the A550 as 
described previously (19).  Samples were blanked with Tyrode's buffer and compared to a 
standard curve of NaNO2.   
 
Immunohistochemistry: After Sham or Hemorrhage (HS) treatment, a 2 cm mid-jejunal section 
was frozen in O.C.T. freezing medium and stored at -80oC until used.  Intestinal cryosections, 6-
8m thick, were fixed in cold acetone.  Non-specific binding was blocked using 10% donkey 
serum or 10% goat serum in PBS.  Tissues were stained for C3 or CD55 using a rat-anti-mouse 
C3 antibody (Hycult Biotechnologies), Armenian hamster-anti-mouse CD55 (Biolegend), 
followed by an appropriate secondary antibody (Jackson Immunoresearch).  Directly conjugated 
rat-anti-mouse F4/80 (eBioscience), rabbit-anti-mouse iNOS (BD Bioscience) or rat-anti-mouse 
TNF was used for macrophage detection and colocalization studies.  Serial sections stained with 
isotype control antibodies were used as background.  Slides were examined by a blinded 
observer by fluorescent microscopy using a Nikon 80i fluorescent microscope and images 
acquired using a CoolSnapCf camera (Photometrics) and MetaVue Imaging software (Molecular 
Devices).  Deposition of C3 was analyzed with Image J software (NIH).  After determining the 
intensity threshold from a positive control, the total positive area of 3-5 photomicrographs per 
tissue was normalized to the appropriate isotype control.  Each treatment group consisted of at 
least 5 animals. 
 
Statistical Analysis: Data are presented as means ± SEM.  Overall differences were determined 
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by two-way ANOVA.  Differences between time points were considered significant if p ≤ 0.05 
as determined by one-way ANOVA with a Newman Keuls post-hoc analysis.  Differences 
between infected and uninfected treatments at specific time points were determined by an 
unpaired t-test analysis (GraphPad). 
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RESULTS 
Helicobacter infection increases intestinal damage. 
To test the hypothesis that chronic H. hepaticus infection alters hemorrhage-induced intestinal 
damage, we subjected uninfected and H. hepaticus infected mice to hemorrhage and examined 
jejunal tissue after 1 h, 2 h or 3 h.  As indicated in Figure 1, minimal mucosal damage occurred 
in uninfected mice (open bars) within 1 h post-hemorrhage (Fig. 1A).  In addition, the villi 
remained tall as indicated by a high villus height/crypt depth ratio (V/C) (Fig. 1B).  In contrast, 
at 2 h post-hemorrhage, uninfected mice exhibited slightly shorter villi and significantly more 
mucosal damage than Sham mice (Fig. 1A-D).  By 3 h post-hemorrhage, intestinal mucosal 
damage decreased, with villi becoming significantly shorter than untreated mice, indicating 
sloughing of the villi and beginning of villi restitution in uninfected mice (Fig. 1A, B, E).   
 
Persistent Helicobacter infection did not significantly alter the injury score or villus height of 
Sham mice when compared to uninfected Sham mice (Fig. 1A, B, C, F).  Similar to uninfected 
mice, at 1 h post-hemorrhage infected mice sustained no significant intestinal damage or 
shortening of the villus height when compared to Sham-treated mice (Fig. 1A, B).  However, by 
2 h post-hemorrhage, infected mice exhibited significantly increased intestinal damage and 
decreased villus height when compared to Sham treatment (Fig. 1A, B, F, G).  Compared to 
similarly treated uninfected mice, infection also significantly increased injury scores and shorter 
villi at 2 h post-hemorrhage (Fig. 1A, B, D, G).  Despite a decrease in injury score at 3 h post 
hemorrhage, the villus height/crypt depth remained similar in infected mice (Fig. 1A, B, H).  The 
lower mucosal injury score in conjunction with low V/C in infected mice at 3 h post-hemorrhage 
suggested the beginning of intestinal restitution (Fig. 1A, B, E, H).  Although intestinal damage 
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was more severe at 2 h post-hemorrhage, by 3 h post hemorrhage intestinal restitution was 
apparent in H. hepaticus infected mice. These data suggest that damage may occur via a different 
mechanism.  
 
Helicobacter infection increases jejunal chemotactic factors.   
As CCL3 (MIP-1), CXCL10 (IP-10) (20) and IL-8 (21) are up-regulated in response to 
infection, we hypothesized that infection may alter the chemotactic secretions and subsequent 
cellular infiltrate following hemorrhage.  To test this hypothesis, we examined the jejunal 
chemokine production from uninfected and infected mice after Sham or hemorrhage treatment.  
In uninfected mice, the jejunum produced CCL3, CCL4 (MIP-1) and KC within 2-3 h post-
hemorrhage (Fig. 2A, B, D open bars).  However, the T cell chemokine CXCL10 remained 
unchanged in uninfected mice (Fig. 2C open bars).  Thus, hemorrhage rapidly increases 
chemokines which recruit innate immune cells.  In contrast, infection alone (Sham treatment) 
induced significant increases in all four chemokines (Fig. 2A, B, C, D solid bars).  In infected 
mice, hemorrhage further increased CCL4 and KC concentrations (Fig. 2B, D solid bars). 
 
Leukotriene B4 (LTB4) also recruits neutrophils and monocytes.  In contrast to the chemokines, 
the intestines of Sham-treated infected or uninfected mice produced similar LTB4 concentrations 
(Fig. 3A).  In response to hemorrhage, in uninfected mice LTB4 significantly increased at 2 h and 
3 h post-hemorrhage (Fig. 3A open bars).  Infection resulted in maximal LTB4 production at 2 h 
post-hemorrhage and was significantly higher than uninfected mice at the same time point (Fig.  
3A).  In contrast to the uninfected mice, LTB4 concentrations within the jejunum significantly 
decreased at 3 h post-hemorrhage in infected mice.  Although the time course of LTB4 
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production appeared shorter, the 2 h post-hemorrhage increase in LTB4 did not correlate with the 
hepatic bacterial load (data not shown), indicating that increased LTB4 production required both 
infection and hemorrhage. 
 
Helicobacter infection increases jejunal neutrophil infiltration which is not further 
increased by hemorrhage. 
To determine if the infection-induced chemokines resulted in an increased cellular infiltrate, we 
quantitated the number of neutrophils in the villi.  Hemorrhage induced a low but significant 
increase in the number of neutrophils by 2 h post-hemorrhage in uninfected mice (Fig. 3B open 
bars).  Correlating with chemokine secretions, Sham-treated jejunal tissue from infected mice 
contained significantly more neutrophils than similarly treated tissue from uninfected mice.  The 
number of neutrophils was not further elevated by hemorrhage (Fig. 3B solid bars).  These data 
indicate that chronic intestinal infection increased neutrophils in the intestinal villi but 
hemorrhage did not further increase the neutrophil infiltrate.  
 
Hemorrhage-induced intestinal damage is complement independent in Helicobacter-
infected mice.   
Helicobacter infection and hemorrhage induce opposing effects, with complement activation 
during hemorrhage and complement inhibition by Helicobacter infection (11, 15, 22).  To 
determine if Helicobacter infection altered the complement mediated intestinal damage, sera C5a 
production and C3 deposition on the intestinal tissue was determined.  As expected, no C3 
deposition was visualized on the intestines of Sham-treated animals in the presence or absence of 
infection (Fig. 4A). In uninfected animals, hemorrhage induced significant C3 deposition on the 
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intestinal mucosa by 1 h post-hemorrhage, which decreased with time.  In contrast, Helicobacter 
infection attenuated intestinal C3 deposition at all time points examined post-hemorrhage (Fig. 
4A solid bars). Quantitation of the deposition verified that infection significantly decreased C3 
deposition at 1 h post-hemorrhage when compared to similarly treated uninfected mice.  
Similarly, in uninfected mice, hemorrhage significantly elevated sera C5a concentrations when 
compared to sham treatment (Fig. 4B open bars).  However, infection attenuated C5a production 
at all time points following hemorrhage (Fig. 4B solid bars).  Since H. pylori upregulates CD55 
(11), it was possible that H. hepaticus also increased expression of the complement inhibitor on 
intestinal tissue.  Immunohistochemistry demonstrated that prior to hemorrhage, mucosal DAF 
expression increased in infected animals when compared to uninfected animals (Fig. 4C, D).  
Thus, infection increased intestinal DAF expression and subsequently decreased intestinal C3 
deposition and C5a production. 
 
To verify that after infection hemorrhage-induced tissue damage was not complement mediated, 
we depleted C3 by administration of CVF prior to hemorrhage.  As indicated in Fig. 5A (open 
bars), at 2 h post-hemorrhage, CVF treatment significantly attenuated hemorrhage-induced 
intestinal damage in uninfected mice.  However, intestinal damage remained unchanged after 
CVF treatment in H. hepaticus infected mice (Fig. 5A solid bars).  In uninfected mice, CVF 
returned LTB4 production to sham treated concentrations (Fig. 5B open bars) but only attenuated 
hemorrhage-induced LTB4 production in Helicobacter-infected mice (Fig. 5B solid bars).  These 
data indicate that Helicobacter infection increases hemorrhage-induced intestinal damage and 
LTB4 in a complement-independent manner.   
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Helicobacter infection results in a hemorrhage-induced macrophage response. 
LTB4, CCL3 and CCL4 not only activate neutrophils, but also induce secretion of pro-
inflammatory cytokines from macrophages (23).  Therefore, it was likely that infection induced 
macrophage infiltration and subsequent tissue damage.  To test this hypothesis, we examined the 
hemorrhage-induced macrophage infiltration in the jejunum of infected and uninfected mice.  
Using F4/80 as a macrophage marker, immunohistochemistry showed few macrophages in the 
intestinal villi of Sham-treated uninfected mice (0.7 ± 0.3 per villus)(Fig. 6A).  Although not 
significantly different from uninfected mice, intestinal villi from Sham-treated infected mice 
contained 2.6 ± 0.7 macrophages per villus (Fig. 6B).  The number of macrophages per villus 
(2.2 ± 0.3) increased similarly by 2 h post-hemorrhage in the absence of Helicobacter (Fig. 6C).  
However, the number of macrophages in the villi of infected mice increased significantly  (5.4 ± 
0.8) by 2 h post-hemorrhage (Fig. 6D).   
 
The increased number of macrophages suggested that additional pro-inflammatory mediators 
may increase in response to hemorrhage in infected mice.  Although hemorrhage did not increase 
jejunal TNF- in uninfected mice, hemorrhage induced a 4 fold increase in TNF- production in 
H. hepaticus infected mice (Fig. 7A).  In response to HS, tissue sections from Helicobacter 
infected mice indicated that the infiltrating macrophages expressed TNF.  This colocalization 
was not present in Sham-treated or HS-treated uninfected mice (Fig. 7C). Macrophage activation 
results in another damaging inflammatory molecule, NO.  In infected mice, hemorrhage induced 
significantly more NO at 2 h and 3 h post-hemorrhage (Fig. 7B).  Although iNOS expression 
colocalized with F4/80 staining, epithelial cells also stained for iNOS expression (Fig. 7D). 
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Thus, macrophage-secreted TNF- and NO significantly increased in response to hemorrhage in 
Helicobacter-infected but not uninfected mice.   
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Discussion 
Helicobacter spp commonly cause chronic undiagnosed infections.  During H. pylori infection 
the inflammatory response increases similar to hemorrhage (3, 4, 10, 11, 15).  Our data indicate 
that H. hepaticus infection increases hemorrhage-induced intestinal secretions and damage with a 
macrophage infiltration.  In contrast, infection prevented hemorrhage-induced complement 
activation.  Thus, a subclinical H. hepaticus infection modulates hemorrhage-induced damage 
within the mid-jejunum of C57Bl/6 mice. 
 
To examine the mechanism of increased hemorrhage-induced intestinal damage in response to 
Helicobacter infection, we compared the jejunal innate immune components.  H. hepaticus 
infection alone significantly increased intestinal chemokines and resulted in a low but 
significantly increased neutrophil infiltration in the jejunum.  However, intestinal damage 
required both infection and hemorrhage, indicating that the neutrophil response in infected mice 
was not sufficient for tissue damage.  In contrast, LTB4 increased in response to hemorrhage (15) 
and increased synergistically in response to hemorrhage and infection.  Known to recruit 
neutrophils, monocytes/macrophages, eosinophils and T cells to sites of inflammation (24, 25), 
LTB4 did not appear to recruit either the neutrophils or macrophages, as the cellular infiltration 
preceded the increased eicosanoid production.  Previous studies indicated that inhibitors of the 5-
lipoxygenase pathway decreased H. pylori-induced IL-8 production by both gastric epithelium 
and macrophage cell lines (26).  The current study indicates that H. hepaticus increases the 
mouse homolog of IL-8, KC.  However, KC elevation was LTB4 independent, as infection alone 
increased the chemokine and infection and hemorrhage synergized to produce maximal LTB4.  
Interestingly, LTB4 secretion was not attenuated after complement depletion suggesting the 
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involvement of another molecular pathway in the production of LTB4.  One possible pathway 
includes the Toll-like receptors (TLRs), which are expressed on both macrophages and intestinal 
epithelial cells.  Recent studies indicate that H. pylori induction of another eicosanoid, 
prostaglandin E2, required TLR2 or TLR9 (27). In addition, prostaglandin E2 production in 
response to ischemic conditions requires TLR4 (28).   
 
Multiple lines of evidence indicate a role for complement activation in hemorrhage-induced 
damage.  Use of complement inhibitors, including soluble complement receptor 1 and C5a 
receptor antagonist, attenuated endothelial and intestinal mucosal damage and inflammation (14, 
15).  We showed that hemorrhage induces intestinal C3 deposition in uninfected but not infected 
mice. In addition, depletion of C3 with CVF attenuated hemorrhage-induced damage only in 
uninfected animals. These results are likely due to Helicobacter-induced increased DAF 
expression.  As a natural complement regulatory protein on cellular membranes, DAF accelerates 
decay of the C3 and C5 convertases resulting in limited complement-mediated tissue damage.  
Up-regulation of DAF occurs during H. pylori infection on gastric epithelial cells (11) similar to 
increased DAF expression in the mid-jejunum.  In another model of intestinal damage, 
administration of soluble DAF attenuates intestinal and lung damage resulting from ischemic 
events in other organs (29).  Although complement is an innate immune component, recent 
studies indicate that DAF regulates adaptive immunity by limiting T cell production of IL-2 and 
IFN (30).  It is possible that similar attenuation of T cell cytokines occurs in response to 
hemorrhage during a subclinical infection.  Together these data indicate that in mice, H. 
hepaticus infection changes the mechanism of hemorrhage-induced damage by attenuating 
complement activation.   
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Despite attenuation of complement-mediated tissue damage in infected mice, hemorrhage 
induced significantly more intestinal damage (at 2 h post-hemorrhage) compared to uninfected 
mice.  Although the ability of Helicobacter to colonize and subsequently modulate the immune 
response to further stimuli is not fully understood, our data indicate that macrophages, TNF- 
and NO may contribute to the response.  We demonstrate that hemorrhage induces a significant 
macrophage infiltration in Helicobacter-infected mice, which is not seen in uninfected mice. In 
addition, immunohistochemistry indicates that the infiltrating macrophages express TNF and 
iNOS. However, other intestinal cells also express iNOS.  Preliminary evidence suggests that 
both macrophages and intestinal epithelial cells release NO in the jejunum of infected mice after 
hemorrhage.  Excess NO may contribute to the damage of the intestinal tight junctions (31) 
increasing the risk of sepsis in response to hemorrhage in infected mice.  Unlike the 
Helicobacter-resistant C57Bl/6 mice in the current study, epithelial cells and macrophages from 
H. hepaticus-infected, immunocompromised Rag2-/- mice, secreted increased TNF and NO in the 
urinary tract in the absence of hemorrhage (7).  Using inducible NO synthase inhibitors, other 
studies indicated that NO induces significant intestinal damage in multiple animal models (32, 
33).  Thus, it is likely that increased macrophage infiltration and subsequent NO and TNF- 
production is responsible for the increased intestinal damage in Helicobacter infected mice.   
 
Helicobacter bacterial DNA was found in the liver, colon and cecum of infected animals and 
approximately 10% of infected animals expressed H. hepaticus DNA in the jejunum (data not 
shown).  Despite the absence of bacterial DNA in the jejunum, cytokines and chemokines were 
significantly elevated in all infected Sham-treated mice.  The mechanism of this inflammatory 
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response is currently unknown.  However, it is similar to the pathogenesis of upper 
gastrointestinal tract inflammation in Crohn’s disease, which is associated with up-regulation of 
cytokines and chemokines in the duodenum (34).  A possible mechanism involves the transport 
of bacterial products between organs via the lymph.  Previous findings indicate that the presence 
of bacterial DNA increases the inflammatory response to hemorrhagic shock (17).  Thus, in 
Helicobacter-infected mice, bacterial components in the lymph may increase the response to 
hemorrhage.  In addition, the infection-induced, intestinal neutrophils may interact with the 
hemorrhage-induced macrophage infiltration. This interaction would be similar to shock-
activated neutrophils in the lung interacting with alveolar macrophages resulting in an 
exaggerated inflammatory response (35).  Although the exact mechanism is currently unknown, 
our data indicate that the presence of Helicobacter in the liver or colon alters the cytokine and 
chemokine response in the jejunum after hemorrhage. 
 
In summary, we demonstrated that chronic H. hepaticus infection significantly alters the 
inflammatory response in a fixed volume mouse model of hemorrhage in C57Bl/6 mice.  
Helicobacter infection modulated the hemorrhage-induced pathology by increasing DAF 
expression on the intestinal mucosa and attenuating complement-mediated tissue damage.  The 
increased tissue damage observed is correlated with a hemorrhage-induced macrophage 
infiltration not seen in uninfected mice.  We demonstrated that significant concentrations of 
TNF- and NO accompany the hemorrhage-induced macrophage infiltration into the jejunum of 
infected mice.  Taken together, H. hepaticus infection modulates the mechanism of hemorrhage-
induced tissue damage and inflammation, such that complement inhibitors are ineffective.  These 
data indicate that chronic, low level infections influence the response to trauma and should be 
 22
considered when designing and administering therapeutics. 
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FIGURE LEGENDS 
Figure 1.  Helicobacter infection increased intestinal damage at 2 h post-hemorrhage.  
Mucosal injury (A) and villus height/crypt depth ratio (B) were determined from H&E stained 
jejunal sections from Helicobacter-infected (solid bars) and uninfected (open bars) after Sham or 
1, 2 or 3 h post-hemorrhage (HS) treatment.. Each bar is the average ± SEM of 6-10 mice per 
group.  (*) indicates p ≤ 0.05 compared to respective Sham treatment and (indicates p ≤ 0.05 
compared to similar treatment of uninfected animals.  C-H) Representative photomicrographs of 
H&E stained intestinal sections from infected (F, G, H) and uninfected (C, D, E) Sham-treated 
(C, F), 2 h post-HS treated (D, G) or 3 h post-HS treated (E, H) mice.  Original 
photomicrographs are 200X magnification.   
 
Figure 2.  Helicobacter infection induced intestinal chemotactic factors.  Ex vivo jejunal 
chemokines CCL3 (A), CCL4 (B), CXCL10 (C), and KC (D) produced by intestinal tissue 
sections from infected (solid bars) and uninfected (open bars) mice subjected to Sham or  
hemorrhage (HS) treatment were determined by multiplex analysis.  Chemokine concentrations 
were normalized to tissue protein content and expressed as pg per mg of intestinal tissue.  Each 
bar represents the average ± SEM with 4-10 mice per group.  (*) indicates p ≤ 0.05 compared to 
respective Sham treatment and ( indicates p ≤ 0.05 compared to similar treatment of uninfected 
animal. 
 
Figure 3.  Intestinal LTB4 and neutrophil infiltration are induced by hemorrhage and 
Helicobacter infection.  A) Ex vivo intestinal LTB4 production by Helicobacter-infected (solid 
bars) and uninfected (open bars) mice subjected to Sham or hemorrhage (HS) treatment was 
measured.  Each bar represents the average ± SEM with 5-10 animals per group. B) Neutrophils 
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(PMN) present in villi of each treatment group were counted from formalin fixed H&E stained 
mid-jejunal intestinal sections at 1000X and are presented as PMN per high powered field.  Each 
bar represents the average of 4-10 animals. (*) indicates p ≤ 0.05 compared to Sham treatment 
and (indicates p ≤ 0.05 compared to similar treatment of uninfected animals.   
 
Figure 4.  Helicobacter infection decreased intestinal C3 deposition and increased DAF 
(CD55) expression following hemorrhage.  Mid-jejunal sections from uninfected (open bars, 
C) and Helicobacter-infected (solid bars, D) C57Bl/6 mice after Sham or hemorrhage (HS) 
treatment were stained for C3 deposition (A) and DAF expression (C, D).  Sera C5a was 
quantitated by ELISA (B). Each bar represents the average ± SEM of 8-10 mice per group.   (*) 
indicates p ≤ 0.05 compared to the respective Sham treatment and (indicates p ≤ 0.05 
compared to similar treatment of uninfected animals.  Original magnification of 
photomicrographs is 200X.   
 
Figure 5.  Cobra Venom Factor (CVF) depletion of C3 did not attenuate hemorrhage-
induced jejunal tissue damage in Helicobacter-infected mice.  After Helicobacter-infected 
(solid bars) and uninfected (open bars) mice were subjected to Sham, or Hemorrhage (HS) in the 
presence of CVF treatment,  mucosal injury (A) or jejunal LTB4 (B) production were quantitated 
at 2 hr. Each bar represents the average ± SEM of 6-10 mice per group.  (*) indicates p ≤ 0.05 
compared to similar Sham treatment and  indicates p ≤ 0.05 compared to respective 
uninfected treatment.   

Figure 6.  Hemorrhage and infection increased F4/80 macrophages in the intestinal villi.  
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Mid-jejunal tissue sections from uninfected (A, C) and Helicobacter-infected (B, D) C57Bl/6 
mice after Sham (A, B) or hemorrhage (HS) (C, D) treatment were stained for F4/80.  Original 
magnification of photomicrographs (A-D) is 400X and the inset (D) is enlarged 3 fold. Data are 
representative of five individual experiments with 3-4 photos per treatment group in each 
experiment. Bar = 20 m 
 
Figure 7.  Helicobacter infection increased jejunal TNF- and NO production.  Ex vivo 
generated mid-jejunal concentrations of TNF- and nitric oxide (NO) (B) from H. hepaticus 
infected (solid bars) and uninfected (open bars) mice were measured. Each bar represents the 
average ± SEM with 3-10 mice per group.  (indicates p ≤ 0.05 compared to similar Sham 
treatment and  indicates significant difference (p≤ 0.05) compared to similarly treated 
uninfected mice. (C, D) After hemorrhage, F4/80 (Red) co-localized with TNF- (C) or iNOS ( 
D) expression (Green) in the mid-jejunum of  Helicobacter-infected mice.  
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